Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $185.77M.
ENTERPRISE VALUE (EV)
$185.77M
Arcturus Therapeutics Holdings Inc.
Market Cap
$416.68M
Enterprise Value (EV)
$185.77M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $416.68M | $185.77M |
| Carlsmed, Inc. (CARL)vs › | $415.93M | $391.60M |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $410.54M | $334.42M |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $408.21M | $517.41M |
| Shoulder Innovations, Inc. (SI)vs › | $406.47M | $396.86M |
| Editas Medicine, Inc. (EDIT)vs › | $428.16M | $261.85M |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | $517.54M |
| Assembly Biosciences, Inc. (ASMB)vs › | $450.64M | $420.71M |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | $448.75M |
| Canopy Growth Corporation (CGC)vs › | $373.40M | $331.65M |
Market Cap
$416.68M
Total Debt
$0.00
Cash
$230.91M
Enterprise Value
$185.77M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
